WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
Registration Still Open!
Online educational conference - 3 afternoons of multi-professional topic-focused education
Tues 23rd - Thurs 25th of April /13:00-16:30
Register > Here
View a programme > Here
BASL ANNUAL MEETING
8th-11th October 2024
BASL Annual Meeting 2024 - Tuesday 8th - Friday 11th October, including BLTG Transplant Meeting & BLNA Meeting. The venue is Harrogate Convention Centre, Harrogate. Abstract Submission Open - closes 9am 7th June 2024 - read more on the Events page here. Submit an Abstract here. A programme and registration will be available soon.
BASL ANNUAL MEETING
REGISTER HERE
BLNA
MEETING
REGISTER HERE
BLTG
MEETING
REGISTER HERE
BASL AND BASL SUB-GROUPS
 |
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. |
 |
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care. |
 |
The British Viral Hepatitis Group aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists. |
 |
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group. |
 |
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research. |
 |
British Association for Allied Health Professionals in Liver is a professional group for AHP’s specialising or working with patients with liver conditions. Bringing together specialist hepatology AHP’s from across the four Nations. Their aim is to promote excellence through the provision of AHP care to all patients with liver disorders. |
News
Dr Falk Pharma BASL British Liver Trust Awards – Applications Open!
Read moreCould your team be a candidate for one of these prizes?
We are delighted to share the news with members that applications for the Dr Falk Pharma, BASL British Liver Trust Awards are open.
Dr Falk Pharma, BASL and the British Liver Trust all agree in the power of shared understanding to improve patient outcomes. These awards recognise the need to share excellence in clinical service development and improvements that have clear benefit for people with liver disease. Such work is rarely that of one individual or discipline, thus these awards are designed to enable teams to develop an idea or continue their work.
The awards represent an opportunity to achieve national recognition as well as financial support for career progression.
Dr Falk / BASL Innovation Award
One award up to a value of £2,000 for a project proposal in start-up, which would be completed prospectively over 12-24 months. The lead applicant will need a local mentor to support the project and will be supported to ensure the success of the project. The award is identified to facilitate research in an area relevant to improving either clinical service development or offering a benefit to patients with liver disease.
Dr Falk / BASL Quality and Service Improvement Awards
Two awards with a value of £1,000 to recognise work and projects in progress and / or completed within the last 3 years for which evidence of benefit can be shown. These awards are open to any team of healthcare professionals working in liver disease developing initiatives that have improved patient care.
Applications for both Awards are via the BASL website with a separate application form for each Award.
Click on the appropriate link below to start your application:
- Innovation Award - click here
- Quality and Service Improvement Awards - click here
Please download a copy of the Guidance for Applications document before making your application: Download Dr Falk BASL Award Guidance for Applicants_2024_final.pdf
NB: These are team awards and the lead applicant for both Awards must be a BASL member.
Important dates:
Applications Open - 16th April 2024
Applications Close - 9AM 17th June 2024
Notification of winners by 19th July 2024
Presentation of the Awards with be during the BASL Annual Meeting in Harrogate 8-11th October.
BASL is committed to promoting equality, diversity and inclusion in all aspects of its work and is actively promoting equal opportunities to our activities, including our awards, for all our members regardless of their background, place of work or professional group. We welcome applications from all disciplines in the field of liver healthcare.
Please contact admin@basl.org.uk if you have any questions regarding the application process.
PSC Support Research Grants
Read morePSC Support is inviting funding applications for:
• Project Award £50,000 - worldwide (closing date 01 May 2024)
• Seed Funding Awards £15,000 to generate pilot or proof-of-concept data - worldwide (closing date 01 May 2024)
• Research Training Fellowship (£300,000) - UK-only (closing date 01 June 2024)
More information: https://pscsupport.org.uk/apply-for-funding
New technology could spot and treat liver cirrhosis complications sooner
Read moreA new study is recruiting now. The research will look at the CirrohCare system for managing and treating decompensated cirrhosis. The system uses smart devices to let people check their condition at home. Doctors can see the data in real time with algorithms helping to spot potential problems early. A preliminary study found positive responses from patients and a reduction in hospital treatment.
Find out more
British Liver Trust
Putting a spotlight on liver health: an update from the UK Liver Alliance
Read moreJoin this webinar on Tuesday, 9th April at 5pm for an exclusive update from the UK Liver Alliance, a coalition of more than 30 organisations who are committed to improving liver health.
From pioneering efforts in early detection within primary care to initiatives aimed at reducing variation in hospital care and driving policy change, this event promises insights that are both informative and inspiring. Speakers include Professor Phil Newsome, Dr Rebecca Jones, Dr Andrew Yeoman and Dr Helen Jarvis.
The SHiNE-UK Study (Surveillance and Care for HCC: A National Evaluation) is now live
Read moreThe SHiNE-UK study (Surveillance and Care for HCC: A National Evaluation) is now live.
Further information and all study docs are available on REDCap dashboard here; www.REDCap.link/SHiNE-UKdashboard.
Do you want to help to research an increasingly important clinical question in hepatology? Do you want to get involved in a large national collaborative project with PubMed-cited collaborative authorship?
SHiNE-UK (Surveillance and care for Hepatocellular carcInoma: a National Evaluation) is a multi-centre project aiming to understand HCC surveillance adherence and outcomes, routes to diagnosis and treatment utilisation across the UK.
SHiNE-UK is a trainee-led multicentre retrospective study that is led by the Trainee Collaborative for Research and Improvement for Hepatology (ToRcH-UK) and hosted by Manchester University NHS Foundation Trust. I
This project comprises of 3 threads:
• Survey of the current provision of HCC surveillance and care (site leads only)
• To assess HCC surveillance adherence and outcomes for patients active in surveillance (all sites – projected 20-60 cases per site)
• To assess routes to diagnosis and first line treatment utilisation for incident HCC (network HPB MDT sites only – projected 30-90 cases per site)
All clinicians, including specialist nurses and allied health professionals are encouraged to take part. Local project teams will gather retrospective data between February and July 2024. All data will be submitted anonymously on REDCap. Each site will have a site lead (registrar) with a supervising gastroenterology/hepatology consultant. The study can be registered via your local Audit Department and will not require R&D approval.
If you would like to take part, please access the SHiNE-UK study dashboard which provides the protocol and supporting materials www.REDCap.link/SHiNE-UKdashboard.
Key Dates
27-Nov-2023 - Site registration opens
19-Feb-2024 - REDCap data collection opens
30-Apr-2024 - Site registration closes
31-Jul-2024 - REDCap data collection closes
Download SHiNE-UK Promotional Poster v1.0 04-Feb-24.pdf
If you have any questions, please contact us via committee@torchuk.org. We look forward to working with you on this exciting project!
Best wishes
SHiNE-UK Project Management Group
X @SHiNEUK_study
Events
Join the ILCA Single Topic Workshop, an insightful and unmissable event to delve into systemic therapies, exploring topics such as patient experiences, first-line therapy selection for HCC, second-line therapy options, and groundbreaking advancements in treating BTC. Curious to learn more?
Join ILCA on 26-27 April 2024 in Madrid, Spain.
Link to register: https://ilcalive.org/registration-2/
BASL members are offered a 10% discount - the code to enter upon registration will be included in the February members newsletter or members can contact admin@basl.org.uk .
Join us 08 – 10 May 2024 for a hybrid event accommodating an international audience!
Live at the Radisson Blu Hotel, Stansted Airport, Essex, UK
And Virtual
REGISTRATION NOW OPEN
AMMF’s 2024 cholangiocarcinoma (CCA) conference will bring together an expert faculty to deliver an engaging hybrid event exploring the European and international aspects of CCA.
To register for this event in person, or virtually, and for venue and accommodation information, visit the AMMF website by clicking > Here.
To view the 3-day conference programme click > Here .
Call for Abstracts – Now Open
Deadline - 15 March 2024 - visit the AMMF website for full details, click > Here.
The annual AMMF CCA conference facilitates and encourages the sharing of information amongst interested medics in the UK, Europe and internationally. It provides an opportunity to find out about improvements in treatments, new and ongoing clinical trials, updates on research and encourages collaboration between researchers and medics.
For full information on AMMF’s CCA Conference 2024 and how to register in person or virtual, visit the AMMF website by clicking > Here.
AMMF’s conference will be a CPD accredited event.
08/05/24
REGISTER NOW - through Zoom by clicking HERE
Are you a budding Hepatologist? Or a new consultant wanting to know more about specific areas of Hepatology? Do you want to improve you hepatology knowledge to permit Hepatology curriculum sign off? Have you got questions but not had the opportunity to ask them?
If yes then please join us for the BASL Virtual School of Hepatology Webinar Series 2024/5. The BASL Virtual School of Hepatology Sessions offer an excellent platform for trainees and consultants interested in hepatology, with talks delivered by UK Hepatologists, followed by a Q&A session.
Following the success of the series in 2021, 2022 & 2023 we are running a series of 6 bi-monthly webinars through 2024 and 2025 on a Wednesday evening.
We are delighted to announce our first session and speaker for May:
Session 1: Outpatient management of cirrhosis
Speaker: Dr Dina Mansour
Date: Wednesday 8th May 2024
UK Time: 19:00 – 20:00
FREE to attend for BASL Members.
REGISTER NOW - through Zoom by clicking HERE
Not a member of BASL, then why not join by clicking > HERE
Remember to read the BASL Events Data Protection Disclaimer below before registering Download BASL Events Data Protection Disclaimer_2022.pdf
Please contact kim@basl.org.uk should you have any questions.
Thank you to our supporter:
And our Partner:
This webinar series is supported by Dr Falk and Astra Zeneca. They have had no influence or input into the programme, agenda or content of the meeting.
14/05/24
BASL and BSG have commissioned The Centre for Sustainable Healthcare to run a series of 3 virtual Sustainable Healthcare webinars and this is the second webinar.
Titled: Embedding sustainability into service development and delivery using the SusQI framework
Time: 6- 7pm (UK time) - 45 minute presentation and 15 minute Q&A.
The webinar is FREE to attend for BASL and BSG members and non-members, however, the recordings are only available to BASL and BSG members via catch up.
Not a member? Join BASL > Here .
Registration Open - register by clicking > Here.
(NB: The BSG are kindly organising registration for the webinar)
Speaker: Catherine Richards
Catherine leads the SusQI programme for the SusQI Academy and courses at the Centre for Sustainable Healthcare. An Occupational Therapist by background with experience in Clinical Governance and Quality Improvement in the NHS. Catherine is an experienced Improvement Advisor, with a passion for embedding sustainability into clinical practice and QI.
The final webinar takes place on 16th July titled 'Research in sustainability: the role of carbon footprinting' and registration is open > Here .
BASL BVHG are proud to endorse the European Meeting on HIV & Hepatitis 2024 which is set to take place on 22-24 May 2024 in the Hotel Catalonia Barcelona Plaza in Barcelona, Spain.
Founded more than twenty years ago, this meeting has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. Particular emphasis is placed on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.
Abstract Submission Closed.
Read more and register through the event website here: https://academicmedicaleducation.com/meeting/european-meeting-hiv-hepatitis-2024?tab=4
Quick Links
